Trikafta 80-40-60MG/59.5MG PKT 14S
Ended Awarded
- Contract number
- SPE2DB25FPQZ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,314
Award facts
- Contract value 100% obligated
- $19,314.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,314.19 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Trikafta 80-40-60mg/59.5mg packets (14-count). This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a continuation of DMS Pharmaceutical Group's role as a critical pharmaceutical supplier to the federal government. The award carries no set-aside designation, allowing the vendor to compete on an open basis despite its woman-owned small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The SPE2DB program vehicle enables the DLA to procure branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent performance across an extensive portfolio of medical products delivered to military and federal healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FPQZ0?
SPE2DB25FPQZ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FPQZ0 worth?
The government has obligated $19,314 on SPE2DB25FPQZ0.
Is contract SPE2DB25FPQZ0 an order under another contract?
Yes. SPE2DB25FPQZ0 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQZ0 competed?
The extent of competition for SPE2DB25FPQZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award